|
ZBTB34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.218000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.712000E-02 |
| Normal-vs-Stage2 |
1.639490E-03 |
| Normal-vs-Stage3 |
8.376400E-04 |
| Normal-vs-Stage4 |
1.017810E-03 |
| Stage1-vs-Stage2 |
4.227500E-02 |
| Stage1-vs-Stage3 |
5.449800E-02 |
| Stage1-vs-Stage4 |
3.863900E-02 |
| Stage2-vs-Stage3 |
5.374000E-01 |
| Stage2-vs-Stage4 |
7.671000E-01 |
| Stage3-vs-Stage4 |
7.492400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.941400E-03 |
| Normal-vs-AfricanAmerican |
1.428970E-01 |
| Normal-vs-Asian |
1.821570E-01 |
| Caucasian-vs-AfricanAmerican |
8.153200E-01 |
| Caucasian-vs-Asian |
3.213600E-01 |
| AfricanAmerican-vs-Asian |
6.433600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.621200E-03 |
| Normal-vs-Female |
4.042400E-03 |
| Male-vs-Female |
9.434800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.026400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.516300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.004800E-04 |
| Normal-vs-Age(81-100Yrs) |
5.076300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.834610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.539200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.606300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.053210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.107370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.198000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.455790E-02 |
| Classical-VS-Follicular |
1.92320000036439E-07 |
| Classical-VS-Other |
9.763800E-01 |
| Classical-VS-Normal |
1.070590E-01 |
| Tall-VS-Follicular |
1.860370E-01 |
| Tall-VS-Other |
2.773800E-01 |
| Tall-VS-Normal |
2.396900E-03 |
| Follicular-VS-Other |
1.022370E-01 |
| Follicular-VS-Normal |
1.06489999995851E-06 |
| Other-VS-Normal |
5.192200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.175430E-03 |
| Normal-vs-N1 |
2.215600E-02 |
| N0-vs-N1 |
5.554400E-01 |
|
|
